Видео ютуба по тегу Emcure Pharma Sales

Emcure is truly the place to grow
Emcure is truly the place to grow
Конференция по доходам Emcure Pharma за второй квартал 2026 финансового года
Конференция по доходам Emcure Pharma за второй квартал 2026 финансового года
Emcure Pharma Makes A Stellar Debut, Lists At 31% Premium To Issue Price | CNBC TV18
Emcure Pharma Makes A Stellar Debut, Lists At 31% Premium To Issue Price | CNBC TV18
Why Emcure Pharmaceuticals Could Hit a New All-Time High | Emcure Pharma Share Latest News
Why Emcure Pharmaceuticals Could Hit a New All-Time High | Emcure Pharma Share Latest News
Strong Debut For Emcure Pharma: Lists At 31% Premium
Strong Debut For Emcure Pharma: Lists At 31% Premium
Конференция по итогам квартала 2026 года компании Emcure Pharmaceuticals | Конференция по итогам ...
Конференция по итогам квартала 2026 года компании Emcure Pharmaceuticals | Конференция по итогам ...
Emcure Pharmaceuticals Ltd Q2 FY26 Earnings Conference Call | Concall.in
Emcure Pharmaceuticals Ltd Q2 FY26 Earnings Conference Call | Concall.in
Listing Ceremony of Emcure Pharmaceuticals Limited
Listing Ceremony of Emcure Pharmaceuticals Limited
NAMITA THAPAR'S ASTOUNDING RETURN ON INVESTMENT ON EMCURE PHARMA IPO!!! #business #stockmarket #ipo
NAMITA THAPAR'S ASTOUNDING RETURN ON INVESTMENT ON EMCURE PHARMA IPO!!! #business #stockmarket #ipo
Emcure Pharmaceuticals Earnings Call for Q1FY26
Emcure Pharmaceuticals Earnings Call for Q1FY26
Emcure Pharma IPO Lists At 30% Premium | Namita Thapar & Satish Mehta Share Details | Business News
Emcure Pharma IPO Lists At 30% Premium | Namita Thapar & Satish Mehta Share Details | Business News
Emcure Pharmaceuticals IPO: Growth Plans, Existing Profit & More | All You Need To Know
Emcure Pharmaceuticals IPO: Growth Plans, Existing Profit & More | All You Need To Know
Kotak Instl Equities Initiates Coverage On Emcure Pharma With 'Add' Rating; Target Price Of 1,655/Sh
Kotak Instl Equities Initiates Coverage On Emcure Pharma With 'Add' Rating; Target Price Of 1,655/Sh
Emcure Pharma Gains After Kotak Instl Equities Upgrades It To Buy With Target Of ₹1,680 | CNBC TV18
Emcure Pharma Gains After Kotak Instl Equities Upgrades It To Buy With Target Of ₹1,680 | CNBC TV18
10x Growth Story of Emcure Pharmaceuticals | Shark Tank Judge Ms. Namita Thapar
10x Growth Story of Emcure Pharmaceuticals | Shark Tank Judge Ms. Namita Thapar
Emcure Pharma IPO Summary | CA Rachana Ranade
Emcure Pharma IPO Summary | CA Rachana Ranade
Namita Thapar To Gain ₹127.8 Cr From Emcure Pharma IPO
Namita Thapar To Gain ₹127.8 Cr From Emcure Pharma IPO
Emcure Pharma Ltd Q2 FY’26 Earnings Concall
Emcure Pharma Ltd Q2 FY’26 Earnings Concall
Emcure Pharmaceuticals Q1FY26 Concall | Earnings Conference Call Q1 Results 2026 #Concall
Emcure Pharmaceuticals Q1FY26 Concall | Earnings Conference Call Q1 Results 2026 #Concall
Top 5 pharma companies by market cap | Anurag Aggarwal | #top10 #vs
Top 5 pharma companies by market cap | Anurag Aggarwal | #top10 #vs
Emcure Pharma - Mobile App Preview - EMC131W
Emcure Pharma - Mobile App Preview - EMC131W